The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

Yale researchers found that cannabis-derived compounds CBD, CBG and CBN reduce pain signaling by inhibiting the Nav1.8 ...

Lilly's patent-protected drugs carry strong pricing power ... musculoskeletal disease, and pain, as well as the company's global marketing function. Ricks joined Lilly in 1996 as a business ...

A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent.

A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to ...

For experienced CBD users who want to skip right to the ‘strong stuff,’ this is great ... with less potential side effects than traditional pain medication. “I did notice that I felt ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

(Vertex Pharmaceuticals) “There is relatively strong safety data for short-term use ... pain after 12 weeks — but it is ...